Memphis, TN, United States of America

Qing Cheng

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2008-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Qing Cheng: Innovator in Genetic Research

Introduction

Qing Cheng is a notable inventor based in Memphis, TN (US), recognized for his contributions to genetic research. With a focus on molecular markers and genotyping assays, he has made significant strides in understanding cancer progression and genetic variations.

Latest Patents

Qing Cheng holds 2 patents that showcase his innovative work. His latest patents include a genotyping assay designed to predict gamma glutamyl hydrolase (GGH) activity. This invention discloses single nucleotide polymorphisms (SNPs) in the gene encoding GGH that are associated with reduced GGH activity. The primary SNP involves a change from cytosine to thymine at a specific nucleotide position. Additionally, he has developed methods and kits for detecting these SNPs, along with primers useful for amplifying portions of the GGH gene.

Another significant patent relates to molecular markers that exhibit differential expression patterns in cancer tissue compared to normal tissue. This invention identifies genetic sequences that are up-regulated in cervical cells, providing potential markers for early- or late-onset cervical cancer. These markers can serve as indicators of cancer progression and may lead to the development of therapeutic protocols aimed at treating or preventing cervical cancer.

Career Highlights

Throughout his career, Qing Cheng has worked with esteemed organizations such as St. Jude Children's Research Hospital and Singapore Health Services Pte Ltd. His work in these institutions has allowed him to collaborate with leading experts in the field of genetic research.

Collaborations

Some of his notable coworkers include William Edward Evans and Mary Relling, who have contributed to his research endeavors.

Conclusion

Qing Cheng's innovative work in genetic research and his patents highlight his commitment to advancing the understanding of cancer and genetic markers. His contributions are paving the way for future developments in therapeutic protocols and cancer diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…